Endeavor BioMedicines, a clinical-stage biotech company, has announced promising phase 2a trial results for its lead ...

Closed Loop Medicine, a techbio company specializing in personalized drug-plus-software therapies, and Pharmanovia, a global ...

Proteins present in the blood may be able to predict a person's risk of developing cancer more than seven years before they ...

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, ...

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head ...

Oxford BioDynamics (OBD) and King’s College London (KCL) have partnered to use OBD’s EpiSwitch technology to identify ...

Regeneron Pharmaceuticals’ gene therapy for otoferlin-related hearing loss, a genetic cause of deafness, has restored hearing ...

Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people irrespective of the amount ...

Key competitors include Boehringer Ingelheim’s cathepsin C inhibitor BI-1291583, Regeneron’s anti-IL-33 monoclonal antibody ...

Cambridge-based drug discovery firm Cresset Group has bolstered its global footprint with the establishment of a new Indian ...

Hazel Jones is the interim CEO and chief operations officer at Enhanc3D Genomics. We sat down with her to discuss her leap of ...

Abzena, an end-to-end CDMO for biologics and bioconjugates, will be presenting its latest AbZelect and AbZelectPRO cell line ...